The substance use disorder (SUD) treatment market is experiencing continued growth, driven by heightened public health awareness, policy interventions, and the rising burden of alcohol and drug dependency across both developed and emerging regions. Government initiatives aimed at reducing the social and economic impact of addiction have LED to increased funding for treatment infrastructure and recovery programs.
Health agency reports and clinical research publications have emphasized the role of early intervention and integrated care in improving recovery outcomes. Mental health parity laws and the expansion of insurance coverage have further improved access to treatment services, enabling broader patient participation.
Moreover, the destigmatization of addiction through public education campaigns has encouraged more individuals to seek help, increasing patient volumes. Technology-driven platforms, including teletherapy and mobile recovery apps, are also reshaping access to behavioral therapies and follow-up care. Looking ahead, sustained investment in evidence-based treatment models and expanding mental health services are expected to accelerate growth, with particular momentum seen in alcohol abuse treatment programs and counseling-based therapeutic approaches.
| Metric | Value |
|---|---|
| Substance Use Disorder Treatment Market Estimated Value in (2025 E) | USD 42.4 billion |
| Substance Use Disorder Treatment Market Forecast Value in (2035 F) | USD 71.1 billion |
| Forecast CAGR (2025 to 2035) | 5.3% |
The market is segmented by Type and Treatment and region. By Type, the market is divided into Alcohol Abuse Treatment, Nicotine Abuse Treatment, and Drug Abuse Treatment. In terms of Treatment, the market is classified into Counselling & Behavioural Therapy, Detoxification, Medication, and Support Group. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The Alcohol Abuse Treatment segment is projected to hold 34.1% of the substance use disorder treatment market revenue in 2025, positioning it as the leading type segment. Growth in this area has been driven by the widespread prevalence of alcohol dependency across all age groups and socioeconomic classes.
Health surveillance data and hospital admission records have consistently identified alcohol use as a leading contributor to substance-related health complications, including liver disease, cardiovascular conditions, and neurological disorders. This has resulted in public health programs prioritizing alcohol intervention strategies.
Additionally, the relative social acceptance of alcohol compared to other substances often leads to higher rates of undiagnosed or untreated dependence, prompting increased demand for targeted rehabilitation services. Healthcare providers have scaled up outpatient and inpatient programs to meet this demand, with specialized clinical pathways designed to support detoxification, therapy, and long-term relapse prevention. Continued public health focus, coupled with growing societal recognition of alcohol misuse, is expected to drive further expansion of this segment.
The Counselling & Behavioural Therapy segment is anticipated to account for 42.7% of the substance use disorder treatment market revenue in 2025, leading the treatment segment. This growth has been propelled by the widespread clinical adoption of therapeutic approaches that address the psychological and behavioral components of addiction.
Cognitive-behavioral therapy (CBT), motivational interviewing, and contingency management have been integrated into standard care protocols due to their demonstrated effectiveness in reducing relapse rates and enhancing patient engagement. Treatment centers, both public and private, have expanded their counseling services in response to increased patient referrals and favorable reimbursement policies.
Furthermore, digital platforms offering virtual therapy sessions have widened access for patients in remote or underserved regions, ensuring continuity of care beyond clinical settings. Research institutions and clinical trials have emphasized the long-term efficacy of counseling in supporting sustained recovery, particularly when combined with pharmacotherapy or peer support programs. With growing preference for holistic, patient-centered recovery models, the Counselling & Behavioural Therapy segment is expected to remain central to SUD treatment strategies.
Based on the data in the following table, the global substance use disorder treatment market is expected to exhibit a CAGR from 2025 to 2035. In the first half of the decade (H1) from 2025 to 2035, the CAGR is expected to be 6.3%, declining slightly to 6% in the second half (H2).
| Particular | Value CAGR |
|---|---|
| H1 | 6.3% (2025 to 2035) |
| H2 | 6% (2025 to 2035) |
| H1 | 5.3% (2025 to 2035) |
| H2 | 4.8% (2025 to 2035) |
Over the subsequent period, from H1 2025 to H2 2035, the CAGR is expected to decline gradually to 5.3% in the first half and stay relatively low at 4.8%.
Technological Advancements are likely to Accelerate the Industry Growth
The industry is expected to rise during the forecast period, driven by advances in medical technology, growing addiction prevalence, and increased government efforts to combat addiction.
Advances in telemedicine, a greater emphasis on integrated care, and technologically enabled solutions will drive demand. The industry is rapidly developing as a result of rising public knowledge of various therapies and a rise in the prevalence of drug abuse issues.
Over the projected period, beneficial government actions such as drug awareness campaigns and preventative programs are also expected to drive industry growth. The rise in the number of substance use disorders prompted the establishment of substance use disorder treatment. As drug addiction grows increasingly frequent, technological advancements in the diagnostics industry is likely to propel growth.
Development of Telemedicine to Propel Industry Growth
The development of telemedicine, an emphasis on integrated care, an emphasis on patient centered care, and an increased emphasis on technology enabled solutions are some of the key trends. Telemedicine is an important advancement driving the substance use disorder treatment market size.
Integrated care occurs when healthcare practitioners from many professions work together to offer complete treatment for the entire individual. Substance use disorder treatment facilities are increasingly using this approach as this approach enables more holistic therapy. This approach to substance use disorder treatment puts the patient at the center of the treatment process and acknowledges distinct needs of each person. This care approach focuses on building connections with patients and providing them with the tools and knowledge to overcome addiction.
Support Services and Policies to Provide Lucrative Opportunities
A vital component of reducing the prevalence and severity of substance use disorders is advocating for policy changes and increasing access to services. In order to achieve this goal, it is paramount that health insurance policies cover treatments and services necessary for the patient.
Maintaining follow-up care and receiving ongoing support are essential for preventing relapse. Regular counseling sessions, self-help programs, and group sessions are some of the ways in which counseling can be provided.
Individuals can maintain long-term sobriety and build a sense of community by utilizing recovery support services such as Narcotics Anonymous and Alcoholics Anonymous. Individuals need support from family and partners to stay on track and cope with treatment.
Funding opportunities have been announced by the USA Department of Health and Human Services (HHS) for expanding services for those with substance use disorders. Women in pregnancy and postpartum, as well as adults and families, are the main beneficiaries of these grants. A total of USD 28 million is available for this project.
Stigma Associated with Addiction to Stifle The Industry Growth
The stigma associated with addiction remains a substantial barrier, discouraging people from seeking treatment out of fear of being judged or facing social consequences. Limited access to healthcare services, particularly in rural or underdeveloped regions, exacerbates inequities in treatment availability and cost.
Regulatory constraints and insurance restrictions might impede access to evidence based therapies and drugs, preventing complete care delivery. Insufficient financing for mental health and addiction treatments puts additional strain on resources, restricting the ability of treatment centers and community based programs to fulfill rising demand.
Global substance use disorder treatment demand increased at a CAGR of 4.5% from 2020 to 2025. For the next ten years (2025 to 2035), projections are that expenditure on substance use disorder treatment will reach a CAGR of 5.3%.
During the historical period, the industry grew due to the realization of the need of treating addiction as a serious public health issue. Key factors include increased knowledge, improved diagnostic procedures, and the destigmatization of seeking therapy, which encourages more people to seek assistance.
Advances in medical treatments and therapeutic techniques are projected to improve efficacy, making recovery more achievable. Naloxone and buprenorphine, as well as developing medicines, help to manage withdrawal symptoms and reduce relapse rates.
The growing investment in telehealth or digital health companies focused on SUD treatment has transformed access to care, particularly in distant and disadvantaged regions. This innovation not only expands the scope of treatment, but also removes transportation and schedule hurdles, making easier for people to seek continuous care.
Globally, government initiatives and funding for addiction treatment programs play an important role in fostering industry growth. Increased financing for mental health and addiction services, along with supporting legislation, guarantees that more resources are directed at comprehensive treatment programs.
Public awareness campaigns help to educate communities about the benefits of early intervention and the availability of various treatment choices.
Collaborations and partnerships in the healthcare business promote a culture of continual development and innovation. Pharmaceutical corporations, healthcare providers, and research organizations collaborate to produce more effective and individualized treatment programs.
As the worldwide society prioritizes mental health and addiction treatment, the industry is expected to grow significantly. This rise not only reflects growing demand, but also demonstrates a shared commitment to fighting the global issue of drug use disorders, thereby enhancing the quality of life for millions of people worldwide.
Among Tier 1 companies, industry leaders account for 55.5% of global market share. Several generics and respiratory product players drive revenue through their strong presence and diverse portfolios. As opioid treatments and continued efforts to address legal liabilities remain crucial to growth, these players will continue to contribute to growth.
Growth will be boosted by a strong research & development pipeline over the next few years. Prominent companies within Tier 1 include Purdue Pharma L.P., Indivior plc, and Alkermes plc.
Mid-size companies, with a share of 24.6% in 2025, play a significant role in the regional market. The companies in this category are well-established overseas and possess a deep understanding of the market. Globalization will be aided by advances in technology and therapeutics.
Major companies in tier 2 include Mallinckrodt plc, Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals Ltd., Cipla Limited, and Allergan plc.
Tier 3 comprises the majority of small biopharmaceutical companies operating in niche business. Most of these companies are geared towards supplying active pharmaceutical ingredients under the tier 3 share category. Growth will be influenced by smaller companies exploring digital therapies with innovative programs that have lower market penetration.
The following table shows the estimated growth rates of the top three countries. India and China are set to exhibit substantial growth, recording CAGRs of 5.1% and 4.5%, respectively, through 2035.
| Countries | CAGR 2025 to 2035 |
|---|---|
| India | 5.1% |
| China | 4.5% |
| The United Kingdom | 1.6% |
| France | 2.3% |
| The United States | 1.4% |
India is projected to ascend at a CAGR of 5.1% during the forecast period. Increasing awareness and destigmatization are key factors driving the substance use disorder treatment industry in India. Both government and nongovernmental groups have made substantial efforts to improve public awareness about the reality of addiction, emphasizing that this is a medical illness rather than a moral failure.
Campaigns emphasizing the need of mental health and addiction therapy have helped to eliminate the stigma associated with seeking help, allowing more people to seek treatment.
Media representing addiction as a curable disorder has normalized getting assistance, while instructional initiatives in schools and workplaces encourage early intervention. Significant personalities and celebrities sharing their recovery stories have helped to improve public opinion, making seeking therapy more socially acceptable.
The above improvements have resulted in a surge in demand for professional SUD treatment services including as counseling, rehabilitation centers, and telemedicine alternatives, which is driving the demand.
The United Kingdom is predicted to augment at a CAGR of 1.6% during the projected period. Telemedicine and virtual care are transforming the substance use disorder treatment sector in the United Kingdom, resulting in considerable growth and accessibility. The impact of COVID-19 on the substance use disorder treatment landscape has pushed the implementation of digital health technologies, stressing the importance of remote treatment alternatives.
The flexibility of telemedicine enables constant involvement with healthcare practitioners, which is important for long term healing. Digital technologies provide real time data tracking, enabling more tailored and adaptable treatment techniques.
Government assistance and legal modifications have aided the incorporation of telemedicine in SUD therapy. Telemedicine is not only improving patient outcomes but also increasing access to appropriate care in rural and underserved regions across the United Kingdom.
The United States is expected to thrive at a CAGR of 1.4% during the assessment period. Collaborations and partnerships are important for advancing the substance use disorder treatment sector in the United States. Pharmaceutical corporations, healthcare providers, and research organizations are increasingly working together to improve treatment alternatives and accessibility. Partnerships between drug makers and rehabilitation clinics, for example, guarantee that medication assisted therapy (MAT) is seamlessly integrated into comprehensive care programs.
Collaborations with technology corporations have also resulted in novel telehealth solutions, increasing access to counseling and behavioral treatments. Public private collaborations are prominent, with government institutions sponsoring research and promoting community based projects.
The above strategic relationships not only promote the discovery of novel treatment modalities, but also expedite care delivery, covering a wide range of patients. By combining their knowledge and resources, stakeholders can better address the layered nature of addiction, eventually improving patient outcomes and driving the demand.
| Segment | Detoxification (Treatment) |
|---|---|
| Value Share (2025) | 36.5% |
The detoxification category showed significant growth in 2025, accounting for 36.5%. Substance-related disorders are treated with detoxification as part of the healthcare continuum.
The treatment of individuals suffering from substance use disorders must be administered with the same level of quality and thoroughness regardless of their circumstances. Individuals must receive treatment for substance abuse following detoxification to achieve long-term abstinence.
A detoxification program provides a unique opportunity to intervene during a crisis and encourage people to seek treatment. As part of the detoxification process, it is essential to develop a therapeutic alliance with patients in order to motivate them to continue their treatment process. Treatment outcomes can be improved with supportive and compassionate care, along with medication.
Symptoms of comorbid mental health disorders can be more effectively treated if detoxification is undertaken concurrently with treatment for the comorbid mental health disorders. In addition to substance use disorders, many individuals who suffer from mental health disorders also experience substance use disorders. Managing these comorbid conditions can assist in improving the retention and effectiveness of treatment.
| Segment | Alcohol Abuse Treatment (Type) |
|---|---|
| Value Share (2025) | 51.5% |
In 2025, the alcohol abuse treatment segment LED the substance use disorder treatment market, with a share of 51.5%. This growth is a reflection of growing awareness about the alcohol dependency and the availability of specialist treatment choices. The increased use of medication assisted is a key substance use disorder treatment market opportunity.
Leading treatment institutions are improving their programs by combining cognitive behavioral therapy (CBT), counseling, and support groups, resulting in complete care models suited to individual requirements. Advances in telemedicine are increasing access to therapy, particularly in underprivileged regions, allowing more people to seek assistance and further driving the demand for this segment which is likely to increase.
The substance use disorder treatment market is extremely competitive and constantly developing, driven by rising demand for effective treatment options. Pharmaceutical firms, rehabilitation institutions, and specialist clinics provide a variety of therapies, including medication assisted therapy (MAT), behavioral therapies, and holistic methods.
Leading companies in the substance use disorder treatment market are focusing on strengthening their position in the market through mergers and acquisitions activity in the SUD treatment sector. Venture capital or private equity funds targeting innovative SUD treatment options and also making considerable investment in telehealth or digital health companies focused on SUD treatment to ease SUD treatment market risks.
Rehabilitation institutions promote comprehensive therapy, incorporating medical detox, counseling, and aftercare programs. The introduction of telehealth services has created new rivals, such as BetterHelp, which provide remote counseling and assistance. Innovation and regulatory changes have a substantial impact, with continual research into novel drugs and therapeutic procedures improving treatment efficacy.
Recent Developments
The segment is classified into alcohol abuse treatment, nicotine abuse treatment and drug abuse treatment.
Based on treatment type, the industry is classified into detoxification, counseling & behavioral therapy, medication and support group.
Analysis of the substance use disorder treatment market has been carried out in key countries of North America, Latin America, Western Europe, South Asia, East Asia, Eastern Europe and Middle East & Africa.
The global substance use disorder treatment market is estimated to be valued at USD 42.4 billion in 2025.
The market size for the substance use disorder treatment market is projected to reach USD 71.1 billion by 2035.
The substance use disorder treatment market is expected to grow at a 5.3% CAGR between 2025 and 2035.
The key product types in substance use disorder treatment market are alcohol abuse treatment, nicotine abuse treatment and drug abuse treatment.
In terms of treatment, counselling & behavioural therapy segment to command 42.7% share in the substance use disorder treatment market in 2025.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Used EV Market Size and Share Forecast Outlook 2025 to 2035
Used Commercial Kitchen Equipment Market Size and Share Forecast Outlook 2025 to 2035
Used Restaurant Equipment Market Size and Share Forecast Outlook 2025 to 2035
Used Commercial Freezer Market Size and Share Forecast Outlook 2025 to 2035
Used E-Scooter Market Growth - Trends & Forecast 2024 to 2034
User Retention Software Market
Used Passenger Car Sales Market
Museums Tourism Market Trends – Growth, Demand & Forecast 2025 to 2035
Fuse Combination Unit Market Growth - Trends, Analysis & Forecast by Type, Current Rating, Application, End-use Industry and Region through 2035
Houseware Market Size and Share Forecast Outlook 2025 to 2035
Household Kitchen Appliances Market Size and Share Forecast Outlook 2025 to 2035
Mouse RNase Inhibitor Market Size and Share Forecast Outlook 2025 to 2035
Mouse Elevated Cross Maze Market Size and Share Forecast Outlook 2025 to 2035
Household Care Wipes Market Size and Share Forecast Outlook 2025 to 2035
Household Refrigerators and Freezers Market Analysis - Size, Share, & Forecast Outlook 2025 to 2035
Household Water Dispensers Market Analysis by Growth, Trends and Forecast from 2025 to 2035
Household Appliances Market Trends – Growth & Forecast 2025 to 2035
Household Robot Market Insights – Growth & Forecast 2024-2034
Household & Cleaning Container Market
Household Aluminum Foil Market
Substance Use Disorder Treatment Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
